Relationship between the duration of the basal QRS complex and electrical therapies for ventricular tachycardias among ICD patients

PACE - Pacing and Clinical Electrophysiology

Volumn 33, Issue 5, 2010, Pages 596-604

  Jiménez Candil, Javier ^a   Ruiz, María ^a   Herrero, Jesús ^a   León, Víctor ^a   Martín, Ana ^a   Moriñigo, José ^a   Ledesma, Claudio ^a   Martín Luengo, Cándido ^a  

^a HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

Author keywords

Antitachycardia pacing; Implantable cardioverter defibrillator; Shock; Ventricular tachycardia

Indexed keywords

AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

ADULT; AGED; ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; DEFIBRILLATOR; DRUG USE; ELECTROCARDIOGRAM; ELECTROSTIMULATION THERAPY; HEART LEFT BUNDLE BRANCH BLOCK; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE END DIASTOLIC DIAMETER; HEART LEFT VENTRICLE SIZE; HEART RIGHT VENTRICLE; HEART RIGHT VENTRICLE APEX; HEART VENTRICLE TACHYCARDIA; HIGH ENERGY SHOCK; HUMAN; IMPLANTATION; MAJOR CLINICAL STUDY; QRS COMPLEX; RISK; SENSITIVITY AND SPECIFICITY; ELECTROCARDIOGRAPHY; HEART PACING; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; MIDDLE AGED; PATHOPHYSIOLOGY; TACHYCARDIA, VENTRICULAR; TREATMENT OUTCOME;

AGED; CARDIAC PACING, ARTIFICIAL; DEFIBRILLATORS, IMPLANTABLE; ELECTROCARDIOGRAPHY; HUMANS; MIDDLE AGED; TACHYCARDIA, VENTRICULAR; TREATMENT OUTCOME;

EID: 77951517747     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2009.02648.x     Document Type: Article

References (35)

1. AVID Investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. N Engl J Med 1997 337 : 1576 1583.
2. Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med 1999 341 : 1882 1890.
3. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002 346 : 877 883. (Pubitemid 34984635)
4. Peinado R, Almendral J, Rius T, Moya A, Merino JL, Martinez-Alday J, Perez-Villacastin J, et al. Randomized, prospective comparison of four burst pacing algorithms for spontaneous ventricular tachycardia. Am J Cardiol 1998 82 : 1422 1425, A1428 A1429. (Pubitemid 28565334)
5. Wathen MS, Sweeney MO, DeGroot PJ, Stark AJ, Koehler JL, Chisner MB, Machado C, et al. Shock reduction using antitachycardia pacing for spontaneous rapid ventricular tachycardia in patients with coronary artery disease. Circulation 2001 104 : 796 801.
6. Wathen MS, DeGroot PJ, Sweeney MO, Stark AJ, Otterness MF, Adkisson WO, Canby RC, et al. Prospective randomized multicenter trial of empirical antitachycardia pacing versus shocks for spontaneous rapid ventricular tachycardia in patients with implantable cardioverter-defibrillators: Pacing fast ventricular tachycardia reduces shock therapies (PainFREE Rx II) trial results. Circulation 2004 110 : 2591 2596.
7. Jimenez-Candil J, Arenal A, Garcia-Alberola A, Ortiz M, del Castillo S, Fernandez-Portales J, Sanchez-Munoz J, et al. Fast ventricular tachycardias in patients with implantable cardioverter-defibrillators: Efficacy and safety of antitachycardia pacing. A prospective and randomized study. J Am Coll Cardiol 2005 45 : 460 461. (Pubitemid 40186801)
8. Daubert JP, Zareba W, Cannom DS, McNitt S, Rosero SZ, Wang P, Schuger C, et al. Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: Frequency, mechanisms, predictors, and survival impact. J Am Coll Cardiol 2008 51 : 1357 1365. (Pubitemid 351443082)
9. Namerow PB, Firth BR, Heywood GM, Windle JR, Parides MK. Quality-of-life six months after CABG surgery in patients randomized to ICD versus no ICD therapy: Findings from the CABG Patch Trial. Pacing Clin Electrophysiol 1999 22 : 1305 1313.
10. Schron EB, Exner DV, Yao Q, Jenkins LS, Steinberg JS, Cook JR, Kutalek SP, et al. Quality of life in the antiarrhythmics versus implantable defibrillators trial: Impact of therapy and influence of adverse symptoms and defibrillator shocks. Circulation 2002 105 : 589 594. (Pubitemid 34123433)
11. Poole JE, Johnson GW, Hellkamp AS, Anderson J, Callans DJ, Raitt MH, Reddy RK, et al. Prognostic importance of defibrillator shocks in patients with heart failure. N Engl J Med 2008 359 : 1009 1017.
12. Josephson ME, Horowitz LN, Farshidi A, Kastor JA. Recurrent sustained ventricular tachycardia. 1. Mechanisms. Circulation 1978 57 : 431 440. (Pubitemid 8284518)
13. Mazzoleni A, Curtin ME, Wolff R, Reiner L, Somes G. On the relationship between heart weights, fibrosis, and QRS duration. J Electrocardiol 1975 8 : 233 236.
14. Yamada T, Fukunami M, Ohmori M, Iwakura K, Kumagai K, Kondoh N, Tsujimura E, et al. New approach to the estimation of the extent of myocardial fibrosis in patients with dilated cardiomyopathy: Use of signal-averaged electrocardiography. Am Heart J 1993 126 : 626 631. (Pubitemid 23274295)
15. Epstein AE, DiMarco JP, Ellenbogen KA, Estes NA, 3rd., Freedman RA, Gettes LS, Gillinov AM, et al. ACC/AHA/HRS 2008 Guidelines for device-based therapy of cardiac rhythm abnormalities: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): Developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. Circulation 2008 117 : e350 e408.
16. Swerdlow CD, Chen PS, Kass RM, Allard JR, Peter CT. Discrimination of ventricular tachycardia from sinus tachycardia and atrial fibrillation in a tiered-therapy cardioverter-defibrillator. J Am Coll Cardiol 1994 23 : 1342 1355. (Pubitemid 24158002)
17. Hook BG, Marchlinski FE. Value of ventricular electrogram recordings in the diagnosis of arrhythmias precipitating electrical device shock therapy. J Am Coll Cardiol 1991 17 : 985 990.
18. Garcia-Alberola A, Yli-Mayry S, Block M, Haverkamp W, Martinez-Rubio A, Kottkamp H, Breithardt G, et al. RR interval variability in irregular monomorphic ventricular tachycardia and atrial fibrillation. Circulation 1996 93 : 295 300. (Pubitemid 26031488)
19. Josephson M. Recurrent ventricular tachycardia. New York, Lippincott Williams and Wilkins In : Josephson M ed.) Clinical Cardiac Electrophysiology.
20. Sheridan DJ, Culling W, Penny WJ. Electrophysiological disturbances associated with acute myocardial infarction. Eur Heart J 1986 7 (Suppl B 11 18. (Pubitemid 16073905)
21. Elhendy A, Hammill SC, Mahoney DW, Pellikka PA. Relation of QRS duration on the surface 12-lead electrocardiogram with mortality in patients with known or suspected coronary artery disease. Am J Cardiol 2005 96 : 1082 1088. (Pubitemid 41416599)
22. Rubart M, Zipes DP. Genesis of Cardiac Arrhythmias. Electrphysiological Considerations.
23. Ahmad M, Bloomstein L, Roelke M, Bernstein AD, Parsonnet V. Patients' attitudes toward implanted defibrillator shocks. Pacing Clin Electrophysiol 2000 23 : 934 938. (Pubitemid 30413598)
24. Dunbar SB, Kimble LP, Jenkins LS, Hawthorne M, Dudley W, Slemmons M, Langberg JJ. Association of mood disturbance and arrhythmia events in patients after cardioverter defibrillator implantation. Depress Anxiety 1999 9 : 163 168. (Pubitemid 29316079)
25. Irvine J, Dorian P, Baker B, O'Brien BJ, Roberts R, Gent M, Newman D, et al. Quality of life in the Canadian Implantable Defibrillator Study (CIDS). Am Heart J 2002 144 : 282 289. (Pubitemid 34879652)
26. Luderitz B, Jung W, Deister A, Manz M. Patient acceptance of implantable cardioverter defibrillator devices: Changing attitudes. Am Heart J 1994 127 : 1179 1184. (Pubitemid 124006927)
27. Bode-Schnurbus L, Bocker D, Block M, Gradaus R, Heinecke A, Breithardt G, Borggrefe M. QRS duration: A simple marker for predicting cardiac mortality in ICD patients with heart failure. Heart 2003 89 : 1157 1162. (Pubitemid 37164003)
28. Stecker EC, Zargarian M, Dogra V, John BT, Kron J, McAnulty JH, Chugh SS. Native QRS duration predicts the occurrence of arrhythmic events in ICD recipients. Europace 2006 8 : 859 862. (Pubitemid 44550615)
29. Iuliano S, Fisher SG, Karasik PE, Fletcher RD, Singh SN. QRS duration and mortality in patients with congestive heart failure. Am Heart J 2002 143 : 1085 1091. (Pubitemid 34666902)
30. Koga Y, Wada T, Toshima H, Akazawa K, Nose Y. Prognostic significance of electrocardiographic findings in patients with dilated cardiomyopathy. Heart Vessels 1993 8 : 37 41. (Pubitemid 23099164)
31. Kashani A, Barold S. Significance of QRS complex duration in patients with heart failure. J Am Coll Cardiol 2005 46 : 2183 2192. (Pubitemid 41785483)
32. Buxton AE, Sweeney MO, Wathen MS, Josephson ME, Otterness MF, Hogan-Miller E, Stark AJ, et al. QRS duration does not predict occurrence of ventricular tachyarrhythmias in patients with implanted cardioverter- defibrillators. J Am Coll Cardiol 2005 46 : 310 316. (Pubitemid 40966861)
33. Dhar R, Alsheikh-Ali AA, Estes NA, 3rd., Moss AJ, Zareba W, Daubert JP, Greenberg H, et al. Association of prolonged QRS duration with ventricular tachyarrhythmias and sudden cardiac death in the Multicenter Automatic Defibrillator Implantation Trial II (MADIT-II). Heart Rhythm 2008 5 : 807 813.
34. Wilkoff BL, Williamson BD, Stern RS, Moore SL, Lu F, Lee SW, Birgersdotter-Green UM, et al. Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: Results from the PREPARE (Primary Prevention Parameters Evaluation) study. J Am Coll Cardiol 2008 52 : 541 550.
35. Kulhkamp V, InSync 7272 ICD World Wide Investigators. Initial experience with an implantable cardioverter-defibrillator incorporating cardiac resynchronization therapy. J Am Coll Cardiol 2002 39 : 790 797.